Back to search

Article

An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization

2022-04-22

Abstract excerpt

<h4>ABSTRACT</h4> Throughout the COVID-19 pandemic, many prophylactic and therapeutic drugs have been evaluated and introduced. Among these treatments, monoclonal antibodies (mAbs) that bind to and neutralize SARS-CoV-2 virus have been applied as complementary and alternative treatments to vaccines. Although different methodologies have been utilized to produce mAbs, traditional hybridoma fusion technology is sti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb1ec9db-207c-58f7-a49f-c16a97764ed4
DOI
10.1101/2022.04.20.488878
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP ImmunizationDOI 10.1101/2022.04.20.488878
mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 variant in the lower and upper respiratory tractSemantic proximity
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized miceSemantic proximity
Broadly Neutralizing Antibodies Against Omicron Variants of SARS-CoV-2 Derived from mRNA-Lipid Nanoparticle-Immunized MiceSemantic proximity
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccinesSemantic proximity
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in miceSemantic proximity
Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in MiceSemantic proximity
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concernSemantic proximity
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Semantic proximity
Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccineSemantic proximity
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variantsSemantic proximity
Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in MiceSemantic proximity
Select a neighboring publication to make it the new centre.